Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon

Menu

Search BMS Clinical Trials
  • Information for Health Care Providers

Considering a Clinical Trial for Your Patients with Blood Cancer?

As part of the Bristol Myers Squibb (BMS) commitment to patient care, we continue to explore blood cancer through extensive clinical research.

divider

Connect Eligible Patients with Appropriate Trials

Click on the the disease for which you are looking to find a trial , then follow these simple steps to connect your patients to a recruiting trial site.

divider

Step 1: Review the Protocols and Determine Eligibility

Click on the link to the disease you are interested in to see the trials available and then click on the trial details to determine the best trial for your patient.

Step 2: Talk to Your Patient

If you find a trial that your patient might qualify for, talk to them about clinical trial participation.

Step 3: Find a Recruiting Site

Select a convenient site location from a list of participating clinical trial sites.

Step 4: Make Contact

Call the principal investigator to discuss eligibility and enrollment for your patient.

divider

Leukemia Clinical Trials

Leukemia is a cancer that starts in blood-forming tissue, such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the bloodstream.1
Explore Leukemia Clinical Trials

Lymphoma Clinical Trials

Lymphoma is a cancer that begins in cells of the immune system.  The two basic categories of lymphomas are Hodgkin Lymphoma and non-Hodgkin Lymphoma.1
Explore Lymphoma Clinical Trials

Multiple Myeloma Clinical Trials

A type of cancer that begins in plasma cells (white blood cells that produce antibodies).1
Explore Multiple Myeloma Clinical Trials

Myelofibrosis Clinical Trials

A disorder in which the bone marrow is replaced by fibrous tissue.1
Explore Myelofibrosis Clinical Trials

Myelodysplastic Syndrome Clinical Trials

Also called MDS, this is a type of cancer in which the bone marrow does not make enough healthy blood cells (white blood cells, red blood cells, and platelets) and there are abnormal cells in the blood and/or bone marrow.1
Explore Myelodysplastic Syndrome Clinical Trials

Have a Question?

Visit our FAQs for Clinical Trials
Visit FAQs

divider

A Commitment to Increasing Diversity

A Commitment to Increasing Diversity

Bristol Myers Squibb is united by our mission to transform patient’s lives through science by discovering, developing, and delivering innovative medicines that help prevail over serious diseases. To that end, we are committed to doing our part to help ensure patients have a fair and just opportunity to achieve optimal health outcomes.

We are working to improve the recruitment of diverse patients with the goal that the clinical trial population becomes more reflective of the real-world population and the people impacted by the diseases studied.

divider